• MIPS 2021—What’s New With Improvement Activities

    This content is excerpted from EyeNet’s MIPS 2021; also see the Academy’s MIPS hub page.


    The improvement activities performance category is largely the same as last year, though CMS has clarified the requirements for a COVID-19 activity that was introduced last year, and it also modified the descrip­tions for two improvement activities.

    IA_ERP_3 has a new name: COVID-19 clinical data reporting with or without clinical trial. CMS launched this high-weighted improvement activity in March 2020, but the activity’s initial name—COVID-19 clinical trials—proved to be misleading. Later in 2020, the agency renamed the activity to clarify that you don’t have to be involved in a clinical trial.   

    IA_AHE_7: Comprehensive eye exams. CMS expanded its description of this medium-weighted activity to include promoting access to vision rehabilitation services.   

    IA_BE_4: Engagement of patients through improvements in patient portal. CMS has expanded the description of this medium-weighted activity. It has added language that:

    • includes caregivers as potential portal users;
    • clarifies that the portal’s use should be bidirectional and its primary use should be clinical, not just administrative; and
    • adds a list of examples of bidirectional, clinical use.

    Previous: What’s New With Promoting Interoperability

    Next: What’s New With Cost

    DISCLAIMER AND LIMITATION OF LIABILITY: Meeting regulatory requirements is a complicated process involving continually changing rules and the application of judgment to factual situations. The Academy does not guarantee or warrant that regulators and public or private payers will agree with the Academy’s information or recommendations. The Academy shall not be liable to you or any other party to any extent whatsoever for errors in, or omissions from, any such information provided by the Academy, its employees, agents, or representatives.

    COPYRIGHT© 2021, American Academy of Ophthalmology, Inc.® All rights reserved. No part of this publication may be reproduced without written permission from the publisher. American Academy of Ophthalmic Executives® and IRIS® Registry, among other marks, are trademarks of the American Academy of Ophthalmology®.

    All of the American Academy of Ophthalmology (AAO)–developed quality measures are copyrighted by the AAO’s H. Dunbar Hoskins Jr., MD, Center for Quality Eye Care (see terms of use).